Disorders of mitochondrial fatty acyl‐CoA β‐oxidation
The DOI matches its Crossref record; 180 of the 180 references it cites were found in a registry or an index.
Abstract
In recent years tremendous progress has been made with respect to the enzymology of the mitochondrial fatty acid β‐oxidation machinery and defects therein. Firstly, a number of new mitochondrial β‐oxidation enzymes have been identified, including very‐long‐chain acyl‐CoA dehydrogenase (VLCAD) and mitochondrial trifunctional protein (MTP). Secondly, the introduction of tandem MS for the analysis of plasma acylcarnitines has greatly facilitated the identification of patients with a defect in fatty acid oxidation (FAO). These two developments explain why the number of defined FAO disorders has increased dramatically, making FAO disorders the most rapidly growing group of inborn errors of metabolism. In this review we describe the current state of knowledge of the enzymes involved in the mitochondrial oxidation of straight‐chain, branched‐chain and (poly)unsaturated fatty acyl‐CoAs as well as disorders of fatty acid oxidation. The laboratory diagnosis of these disorders is described, with particular emphasis on the methods used to identify the underlying enzyme defect and the molecular mutations. In addition, a simple flowchart is presented as a guide to the identification of mitochondrial FAO‐disorders. Finally, treatment strategies are discussed briefly.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients afflicted with these disorders present with nonketotic hypoglycemia, muscle weakness, pronounced elevations in long chain acylcarnitines and systemic carnitine depletion [91].”
From Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused? (2010) · cites this paper as [91]
Citations
Cites
Ciabarra, A., Sullivan, J., Gahn, L., Pecht, G., Heinemann, S., & Sevarino, K. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06498.1995 · Cited by 1,233
(2008) · Encyclopedia of Molecular Pharmacology · doi:10.1007/978-3-540-38918-7_6838 · Cited by 648
Millington, D. S., Kodo, N., Norwood, D. L., & Roe, C. R. (1990) · Journal of Inherited Metabolic Disease · doi:10.1007/bf01799385 · Cited by 571 · cited 1×
“…clear, however, that tandem mass spectrometry is the method of choice for the analysis of acylcarnitines, especially since acylcarnitine proÐles can readily be determined not only in plasma or serum samples but also in blood spots (Millington et al 1990 ; Rashed et al 1995a,b ; Vreken et al 1999).”
Muscle Carnitine Palmityltransferase Deficiency and Myoglobinuria
DiMauro, S., & DiMauro, P. M. M. (1973) · Science · doi:10.1126/science.182.4115.929 · Cited by 477 · cited 2×
“Schaefer and coworkers (1996) described three adult patients from the same family with symptoms of recurrent exercise-induced rhabdomyolysis mimicking adult-type CPT2 deÐciency (DiMauro and DiMauro 1973) except that these patients had an associated peripheral neuropathy.”
BackgroundRashed, M. S., Ozand, P. T., Bucknall, M. P., & Little, D. (1995) · Pediatric Research · doi:10.1203/00006450-199509000-00009 · Cited by 342 · cited 2×
“The proÐle of acylcarnitines in plasma obtained by tandem MS is unique and speciÐc for MCAD deÐciency characterized by elevated concentrations of together with elevated concentrations ofC8-carnitine and (Chace et al 1997 ; Rashed et al 1995b ; Vreken etC6-, C10- C10>1-acylcarnitine al 1999).”
BackgroundUchida, Y., Izai, K., Orii, T., & Hashimoto, T. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48391-3 · Cited by 339 · cited 9×
“It is now clear that the long-chain enzyme identiÐed by Schulz (1974) is in fact a constituent of the mitochondrial trifunctional protein (MTP) identiÐed by Hashimoto and coworkers (Uchida et al 1992).”
BackgroundInfluentialAndresen, B. S., Olpin, S., Poorthuis, B. J. H. M., Scholte, H. R., Vianey-Saban, C., Wanders, R., Ijlst, L., Morris, A., Pourfarzam, M., Bartlett, K., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302261 · Cited by 305 · cited 2×
“Since these reports in 1993, many additional VLCADdeÐcient patients have been described (Andresen et al 1996, 1999 ; Aoyama et al 1995a,b ; Brown-Harrison et al 1996 ; Largilliere et al 1995 ; Merinero et al 1996 ; Ogilvie et al 1994 ; Sluysmans et al 1997 ; Smelt et al 1998) including a series of…”
BackgroundSelf-citationChace, D. H., Hillman, S. L., Van Hove, J. L. K., & Naylor, E. W. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.11.2106 · Cited by 280 · cited 1×
“The proÐle of acylcarnitines in plasma obtained by tandem MS is unique and speciÐc for MCAD deÐciency characterized by elevated concentrations of together with elevated concentrations ofC8-carnitine and (Chace et al 1997 ; Rashed et al 1995b ; Vreken etC6-, C10- C10>1-acylcarnitine al 1999).”
BackgroundRashed, M. S., Bucknall, M. P., Little, D., Awad, A., Jacob, M., Alamoudi, M., Alwattar, M., & Ozand, P. T. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.7.1129 · Cited by 275
Medium–chain acyl-coenzyme A dehydrogenase deficiency: Clinical course in 120 affected children
Iafolla, A. K., Thompson, R. J., & Roe, C. R. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(94)70363-9 · Cited by 274
Research works printed but not linked: 1
- VredendaalPJ van denBergIET StroobantsAK Van DerADL MalingreHE BergerR(1999)Structural organisation of the human short‐chainL‐3‐hydroxyacyl‐CoA dehydrogenase gene.Mamm Genome(in press)..
Cited by
A general introduction to the biochemistry of mitochondrial fatty acid β‐oxidation
Houten, S. M., & Wanders, R. J. A. (2010) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-010-9061-2 · Cited by 1,020
“For almost each enzyme involved in FAO, inherited defects have been described (Wanders et al. 1999; Rinaldo et al. 2002).”
BackgroundSelf-citationFatty Acid Oxidation Disorders
Rinaldo, P., Matern, D., & Bennett, M. J. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.082201.154705 · Cited by 479
The Properties of Lauric Acid and Their Significance in Coconut Oil
Dayrit, F. M. (2015) · Journal of the American Oil Chemists' Society · doi:10.1007/s11746-014-2562-7 · Cited by 479
Fatty acid oxidation is a dominant bioenergetic pathway in prostate cancer
Liu, Y. (2006) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500879 · Cited by 433
Control of mitochondrial β-oxidation flux
Eaton, S. (2002) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00024-8 · Cited by 411
Metadata
- Authors
- Wanders, R. J. A., Vreken, P., den Boer, M. E. J., Wijburg, F. A., Van Gennip, A. H., & IJlst, L.
- Affiliations
- Amsterdam UMC Location University of Amsterdam (NL)
- Departments of Clinical Chemistry Academic Medical Center, University of Amsterdam The Netherlands
- Corresponding author
- Wanders, R. J. A.
- Venue
- Journal of Inherited Metabolic Disease
- Publisher
- Wiley
- Published
- 1999-06
- Volume
- 22
- Issue
- 4
- Pages
- 442-487
- ISSN
- 0141-8955 (ISSN-L)
- 1573-2665
- OpenAlex
- W2147457396
- Cited by
- 257
- References
- 180
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 12 · 2023: 4 · 2022: 9 · 2021: 5 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 7 · 2016: 8 · 2015: 7 · 2014: 12 · 2013: 13 · 2012: 5
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Inherited Metabolic Disease (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- fatty acid beta-oxidation disorders, inborn errors of metabolism, VLCAD, mitochondrial trifunctional protein, acylcarnitines, tandem mass spectrometry, branched-chain fatty acids, polyunsaturated fatty acids, enzyme defects, molecular diagnosis, treatment options
- MeSH terms
- Acyl Coenzyme A, Fatty Acids, Fatty Acids, Unsaturated, Humans, Lipid Metabolism, Inborn Errors, Mitochondria, Oxidation-Reduction, Prenatal Diagnosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disorders of mitochondrial fatty acyl‐CoA β‐oxidation. https://app.cochat.ai/papers/10.1023/a:1005504223140
- The paper
- Wanders, R. J. A., Vreken, P., den Boer, M. E. J., Wijburg, F. A., Van Gennip, A. H., & IJlst, L. (1999). Disorders of mitochondrial fatty acyl‐CoA β‐oxidation. Journal of Inherited Metabolic Disease. https://doi.org/10.1023/a%3A1005504223140
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.